Shrinkage in the brain's hippocampus area associated with cognitive decline

With the rise of new drugs that can target the amyloid-beta plaques in the brain that are an early sign of Alzheimer's disease, new ways are needed to determine whether memory loss and thinking problems are due to Alzheimer's disease or another neurodegenerative disorder.

Related Keywords

United States ,Boston ,Massachusetts ,Belgium ,American ,Belgian ,Bernardj Hanseeuw , ,National Institutes Of Health ,American Academy Of Neurology ,Harvard Medical School ,Queen Elizabeth Medical Foundation ,Belgian Fund For Scientific Research ,American Academy ,National Institutes ,Belgian Fund ,Scientific Research ,Queen Elizabeth Medical ,Hippocampus ,Lzheimer 39s Disease ,Rain ,Dementia ,Drugs ,Neurodegenerative Diseases ,Neurodegenerative Disorder ,Eurology ,Research ,